Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)

被引：0
|
作者：
Jens Jakob
Anna Simeonova
Bernd Kasper
Ulrich Ronellenfitsch
Geraldine Rauch
Frederik Wenz
Peter Hohenberger
机构：
[1] University Medical Center and Medical Faculty Mannheim,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[2] University of Heidelberg,Department of Radiation Oncology
[3] University Medical Center Mannheim,Sarcoma Unit, Interdisciplinary Tumor Center Mannheim
[4] University of Heidelberg,Division of Surgical, Oncology and Thoracic Surgery, Department of Surgery
[5] Mannheim University Medical Center,Institute of Medical Biometry and Informatics
[6] University of Heidelberg,Department of Radiation Oncology
[7] University Medical Center Mannheim,undefined
[8] University of Heidelberg,undefined
[9] University of Heidelberg,undefined
[10] University Medical Center and Medical Faculty Mannheim,undefined
[11] University of Heidelberg,undefined
来源：
Radiation Oncology | / 11卷
关键词：
Sunitinib; Soft Tissue Sarcoma; Dose Limit Toxicity; Intensity Modulate Radiation Therapy; Clinical Target Volume;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)
    Jakob, Jens
    Simeonova, Anna
    Kasper, Bernd
    Ronellenfitsch, Ulrich
    Rauch, Geraldine
    Wenz, Frederik
    Hohenberger, Peter
    RADIATION ONCOLOGY, 2016, 11
  • [2] Combined sunitinib and IMRT for preoperative treatment of locally advanced soft tissue sarcoma: Results of a phase I trial of the German Interdisciplinary Sarcoma Group GISG 03.
    Jakob, Jens
    Simeonova, Anna
    Kasper, Bernd
    Ronellenfitsch, Ulrich
    Rauch, Geraldine
    Wenz, Frederik K.
    Hohenberger, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma
    Jakob, Jens
    Rauch, Geraldine
    Wenz, Frederik
    Hohenberger, Peter
    BMJ OPEN, 2013, 3 (09):
  • [4] Combined Radiation Therapy and Sunitinib for Preoperative Treatment of Soft Tissue Sarcoma
    Jakob, Jens
    Simeonova, Anna
    Kasper, Bernd
    Ronellenfitsch, Ulrich
    Wenz, Frederik
    Hohenberger, Peter
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (09) : 2839 - 2845
  • [5] Combined Radiation Therapy and Sunitinib for Preoperative Treatment of Soft Tissue Sarcoma
    Jens Jakob
    Anna Simeonova
    Bernd Kasper
    Ulrich Ronellenfitsch
    Frederik Wenz
    Peter Hohenberger
    Annals of Surgical Oncology, 2015, 22 : 2839 - 2845
  • [6] Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03)
    Jakob, Jens
    Lesluyes, Tom
    Simeonova-Chergou, Anna
    Wenz, Frederik
    Hohenberger, Peter
    Chibon, Frederic
    Le Guellec, Sophie
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (03) : 280 - 285
  • [7] Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)
    Kasper, Bernd
    Reichardt, Peter
    Pink, Daniel
    Sommer, Michaela
    Mathew, Monika
    Rauch, Geraldine
    Hohenberger, Peter
    MARINE DRUGS, 2015, 13 (01): : 379 - 388
  • [8] Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
    Ronellenfitsch, Ulrich
    Dimitrakopoulou-Strauss, Antonia
    Jakob, Jens
    Kasper, Bernd
    Nowak, Kai
    Pilz, Lothar R.
    Attenberger, Ulrike
    Gaiser, Timo
    Egerer, Gerlinde
    Froehling, Stefan
    Derigs, Hans-Guenter
    Schwarzbach, Matthias
    Hohenberger, Peter
    BMJ OPEN, 2016, 6 (01):
  • [9] Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04)
    Ronellenfitsch, Ulrich
    Karampinis, Ioannis
    Dimitrakopoulou-Strauss, Antonia
    Sachpekidis, Christos
    Jakob, Jens
    Kasper, Bernd
    Nowak, Kai
    Pilz, Lothar
    Attenberger, Ulrike
    Gaiser, Timo
    Derigs, Hans-Guenther
    Schwarzbach, Matthias
    Hohenberger, Peter
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (05) : 1332 - 1339
  • [10] Preoperative Pazopanib in High-Risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04)
    Ulrich Ronellenfitsch
    Ioannis Karampinis
    Antonia Dimitrakopoulou-Strauss
    Christos Sachpekidis
    Jens Jakob
    Bernd Kasper
    Kai Nowak
    Lothar Pilz
    Ulrike Attenberger
    Timo Gaiser
    Hans-Günther Derigs
    Matthias Schwarzbach
    Peter Hohenberger
    Annals of Surgical Oncology, 2019, 26 : 1332 - 1339
12345